Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Dyspnoea, Pulmonary oedema
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Type 2 diabetes mellitus
Diagnostic Lab Data:
CDC 'Split Type': GRPFIZER INC2021186804
Write-up: pulmonary edema; dyspnea; This is a spontaneous report from a non-contactable consumer received via a Pfizer sales representative. A 75-year-old male patient was administered the first dose of bnt162b2 (COMIRNATY) via an unspecified route of administration on 27Jan2021 at a single dose for covid-19 immunisation. Medical history included type 2 diabetes mellitus. The patient''s concomitant medications were not reported. The patient passed away on 01Feb2021 due to pulmonary edema. Patient mentioned experiencing dyspnea 10mins before death. The action taken in response to the events for bnt162b2 was not applicable. It was unknown if an autopsy was performed. The outcome of event dyspnea was unknown. As per attending physician causality not suspected. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Pulmonary oedema
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166